Hospital & Medical Service Plans · SIC 6324

Alignment Healthcare, Inc.

ALHC

Watch

Latest revenue

$1.23B

as of 2026-03-31

Latest net income

$11.4M

as of 2026-03-31

Net margin

0.9%

as of 2026-03-31

Price · 5Y

-8.3% / yr 22.1 pts / yr vs S&P 500 35.2% total
Compare:

Live market

delayed ≤15 min
$16.35
0.12%
Market cap
$3.38B
Enterprise value
$3.38B
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$23.87
52-wk low
$11.63
Beta
Shares out
206.7M

5-year trend

What this company does

AI

Item 1. Business. Our Mission: Improve Healthcare, One Senior at a Time Alignment Healthcare was founded in 2013 with one mission: improve healthcare, one senior at a time. We pursue this mission by focusing on our core values: •always put the senior first; •support the doctor; •use data and technology to revolutionize care; and •act with a serving heart. We created Alignment after our own families faced frustrating experiences within the fragmented healthcare system. Without an advocate to create an integrated, high quality healthcare experience for them, our loved ones were left to navigate a care delivery and insurance landscape fraught with confusion and complexity. Seniors across the…

AI summary unavailable — showing raw filing excerpt

Generated from ALHC's filing dated 2026-02-27

Key risks

AI

Item 1A. Risk Factors. Our business involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes thereto, before making a decision to invest in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, financial condition, operating results and…

AI summary unavailable — showing raw filing excerpt

Generated from ALHC's filing dated 2026-02-27

Profitability

Operating margin

0.4%

109.9%

Net margin

-0.0%

99.6%

Return on equity

-0.4%

99.7%

Return on assets

-0.1%

99.6%

Leverage

Debt / equity

4.94×

27.6%

Long-term debt / equity

1.80×

44.0%

Debt / assets

83.2%

4.6%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$1.23B+33.6%$11.4M+225.3%0.9%

Q4 2025

2025-12-31

$1.04B+43.9%$-1.9M+93.9%-0.2%

Q3 2025

2025-09-30

$983.7M+43.7%$3.7M+114.1%0.4%

Q2 2025

2025-06-30

$1.01B+49.3%$6.6M+127.3%0.7%

Q1 2025

2025-03-31

$918.0M+47.7%$-9.1M+80.4%-1.0%

Q4 2024

2024-12-31

$723.4M$-31.1M-4.3%

Q3 2024

2024-09-30

$684.5M+52.0%$-26.4M+24.6%-3.9%

Q2 2024

2024-06-30

$674.1M+47.5%$-24.0M+15.7%-3.6%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Hospital & Medical Service Plans · SIC 6324

No data yet for industry average

Your notes

Keep private notes on ALHC — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$0

Insider selling

$1.15B

Net activity

−$1.15B

Distinct insiders

11

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2026-05-15

Dawn Christine Maroney

President

Sale30,000$16.09$482.6K
2026-05-11

John E Kao

Chief Executive Officer

Sale280,893$16.85$4.7M
2026-05-11

John E Kao

Chief Executive Officer

Sale17,107$17.54$300.0K
2026-04-15

Dawn Christine Maroney

President

Sale30,000$20.87$626.2K
2026-04-13

John E Kao

Chief Executive Officer

Sale82,299$20.80$1.7M
2026-04-10

John E Kao

Chief Executive Officer

Sale201,900$20.58$4.2M
2026-04-10

John E Kao

Chief Executive Officer

Sale13,801$21.38$295.0K
2026-04-07

James M Head

Chief Financial Officer

Sale11,100$21.08$234.0K
2026-04-07

John E Kao

Chief Executive Officer

Sale132,241$20.67$2.7M
2026-04-07

John E Kao

Chief Executive Officer

Sale117,759$21.40$2.5M
2026-04-01

Christopher J Joyce

Chief Legal and Admin. Officer

Sale18,013$17.79$320.5K
2026-03-23

John E Kao

Chief Executive Officer

Sale118,000$17.48$2.1M
2026-03-19

Andreas P. Wagner

Chief Human Resources Officer

Sale11,602$18.22$211.4K
2026-03-18

Sebastian Burzacchi

COO - Mgmt Services Org

Sale15,361$17.84$274.0K
2026-03-18

Hyong Kim

Chief Medical Officer

Sale18,404$17.84$328.3K
2026-03-18

Christopher J Joyce

Chief Legal and Admin. Officer

Sale25,125$17.84$448.2K
2026-03-18

Dawn Christine Maroney

President

Sale36,749$17.84$655.6K
2026-03-18

John E Kao

Chief Executive Officer

Sale73,046$17.84$1.3M
2026-03-18

Robert L. Scavo

Chief Information Officer

Sale11,285$17.84$201.3K
2026-03-18

Andreas P. Wagner

Chief Human Resources Officer

Sale12,000$17.84$214.1K
2026-03-16

Dawn Christine Maroney

President

Sale30,000$17.48$524.4K
2026-03-12

Robert L. Scavo

Chief Information Officer

Sale3,799$17.48$66.4K
2026-03-12

Robert L. Scavo

Chief Information Officer

Sale245$16.99$4.2K
2026-03-12

Dawn Christine Maroney

President

Sale27,350$17.48$478.0K
2026-03-12

Dawn Christine Maroney

President

Sale1,763$16.99$30.0K
2026-03-12

John E Kao

Chief Executive Officer

Sale45,938$17.48$802.8K
2026-03-12

John E Kao

Chief Executive Officer

Sale2,961$16.99$50.3K
2026-03-10

John E Kao

Chief Executive Officer

Sale180,000$18.19$3.3M
2026-03-04

Andreas P. Wagner

Chief Human Resources Officer

Sale21,118$18.62$393.3K
2026-02-17

Dawn Christine Maroney

President

Sale30,000$20.63$619.0K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns ALHC

Institutional value

$1.39B

Total shares held

79.6M

Distinct holders

163

-100 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1BlackRock, Inc.14.1M$248.0M+363.9K (+2.7%)Added
2VANGUARD PORTFOLIO MANAGEMENT LLC9.7M$171.1MNew
3VANGUARD CAPITAL MANAGEMENT LLC8.0M$140.5MNew
4Invesco Ltd.7.0M$123.3M+797.5K (+12.9%)Added
5WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC5.2M$91.9M+2.9M (+126.2%)Added
6Capital Research Global Investors3.6M$63.3MNew
7Bank of New York Mellon Corp3.3M$58.4M+2.3M (+232.5%)Added
8Voya Investment Management LLC2.8M$49.3M-876.7K (-23.9%)Trimmed
9Capital World Investors2.7M$47.0M+427.9K (+19.1%)Added
10Danica Pension, Livsforsikringsaktieselskab2.5M$44.1M+503.6K (+25.2%)Added
11Allspring Global Investments Holdings, LLC2.5M$43.9M+1.8M (+276.7%)Added
12Nuveen, LLC1.6M$27.8M-556.4K (-26.0%)Trimmed
13VANGUARD FIDUCIARY TRUST CO1.2M$20.5MNew
14JUPITER ASSET MANAGEMENT LTD877.8K$15.5M+112.5K (+14.7%)Added
15MARSICO CAPITAL MANAGEMENT LLC779.8K$13.7M+66.4K (+9.3%)Added
16SEI INVESTMENTS CO739.1K$13.0M+295.6K (+66.7%)Added
17FIRST TRUST ADVISORS LP626.2K$11.0M+4.8K (+0.8%)Added
18FEDERATED HERMES, INC.604.8K$10.7M+33.3K (+5.8%)Added
19ROYCE & ASSOCIATES LP557.9K$9.8M+35.5K (+6.8%)Added
20ENVESTNET ASSET MANAGEMENT INC551.3K$9.7M+527.5K (+2214.4%)Added

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once ALHC's latest filing finishes processing.